MedTrace Logo

Helicobacter Pylori Eradication and Irritable Bowel Syndrome: A Prospective Study

NCT04512898 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2020-08-14

No results posted yet for this study

Summary

H. Pylori is frequently observed in patients with irritable bowel syndrome(IBS). However, the effect of H. pylori eradication on IBS is not clear.

Conditions

  • Irritable Bowel Syndrome

Interventions

DRUG

Triple therapy for H.pylori

Triple therapy of proton pump inhibitors, clarithromycin and metronidazole.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-10
Primary Completion
2020-11-10
Completion
2020-11-10

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04512898 on ClinicalTrials.gov